There is discussion about the potential benefits and risks of microdosing GLP-1 drugs, with some outlets exploring their use for weight loss. Experts appear to be divided on the issue, with some warning against microdosing and others examining its possible effects. The use of GLP-1 drugs, including Ozempic, for microdosing is being evaluated by various health organizations and experts, with no clear consensus emerging.